热门资讯> 正文
小RFK结束COVID-19药物的紧急使用授权
2026-07-01 02:30
- HHS Secretary Robert F. Kennedy Jr. has terminated Emergency Use Authorizations for drugs and medical devices to treat COVID-19.
- The EUAs for drugs and biologics will end in 12 months and in 180 days for medical devices.
- COVID vaccines are not impacted by today's action given that the three shots available in the US, manufactured by Moderna (MRNA), Pfizer (PFE)/BioNTech (BNTX), and Novavax (NVAX) have received traditional approval following their own EUAs.
- Drugs such as Pfizer's Paxlovid (nirmatrelvir/ritonavir) and Merck's (MRK) Lagrevio (molnupiravir) are impacted by the directive.
More on Pfizer, Merck
- Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff
- Antibody-Drug Conjugates: Not Quite Worked Out Yet
- Merck's Oncology Engine Is Still Accelerating
- FDA commissioner contenders down to three - report
- Record-setting healthcare M&A activity to extend through H2: PwC
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。